Home Identification of nucleotide polymorphism within the NeuroD1 candidate gene and its association with type 1 diabetes susceptibility in Iranian people by polymerase chain reaction-restriction fragment length polymorphism
Article
Licensed
Unlicensed Requires Authentication

Identification of nucleotide polymorphism within the NeuroD1 candidate gene and its association with type 1 diabetes susceptibility in Iranian people by polymerase chain reaction-restriction fragment length polymorphism

  • Maryam Soltani asl ORCID logo , Parviz Azimnasab-sorkhabi ORCID logo EMAIL logo , Ali-Akbar Abolfathi and Yashar Hashemi aghdam
Published/Copyright: August 26, 2020

Abstract

Objectives

Diabetes is a serious disease, and the number of affected individuals with diabetes is considerably high. The aim of this study is the identification of NeuroD1 Ala45Thr polymorphism and its association with type 1 diabetes susceptibility in Iranian people.

Methods

Clinical and biochemical characteristics for 146 people (76 diabetics and 70 nondiabetics) were measured, such as fasting blood sugar, triacylglycerol, total cholesterol, age, and weight in each individual. Polymerase chain reaction-restriction fragment length polymorphism technique (MwoI restriction-enzyme) was used for genotyping of the NeuroD1 Ala45Thr polymorphism.

Results

In this study, the frequency of the A allele in diabetic patients in comparison with the healthy control group had a significantly higher percentage (p < 0.01), whereas diabetic patients had the AA genotype, approximately four times more than the healthy control group (p < 0.01). In addition, we observed that fasting blood sugar had a higher concentration in the AA genotype than in AG + GG genotypes (p < 0.01).

Conclusions

The A allele may be a risk factor for the expansion of type 1 diabetes in the Iranian population. However, the NeuroD1 Ala45Thr polymorphism and its role in type 1 diabetes in different populations are controversial.


Corresponding author: Parviz Azimnasab sorkhabi, M.Sc, Department of Biology, Faculty of Science, Ahar Branch, Azad University, No.1403, Danesh3 Ave, Baqmishe, 5158783748, Ahar, Iran, E-mail:

Acknowledgments

The authors would like to thank Dr. Arash Javanmard, Dr. Ali Etemad, Dr. Mohammad Ghorbani, the study staff, and all the participants who made this study possible.

  1. Research funding: None declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organizations played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Ethical approval: The research methods were approved by the local ethic committee, and written informed consent was obtained from all participants in this study.

References

1. Leitner, DR, Fruhbeck, G, Yumuk, V, Schindler, K, Micic, D, Woodward, E, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies – EASO can lead the way. Obes Facts 2017;10:483–92. https://doi.org/10.1159/000480525.Search in Google Scholar PubMed PubMed Central

2. Carey, J, Walters, E, Golditz, A, Soloman, G, Willett, C, Rosner, A. Body fat distribution and risk of non-insulin dependent diabetes mellitus in women. Am J Epidemiol 1997;145:614–19. https://doi.org/10.1093/oxfordjournals.aje.a009158.Search in Google Scholar PubMed

3. Brennan, M, Brown, J, Ntoumanis, N, Leslie, G. Barriers and facilitators to physical activity participation in adults living with type 1 diabetes: a scoping review protocol. JBI Database System Rev Implement Rep 2019. https://doi.org/10.11124/jbisrir-d-19-00219.Search in Google Scholar PubMed

4. Martinov, T, Fife, BT. Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance. Ann N Y Acad Sci 2020;1461:73–103. https://doi.org/10.1111/nyas.14106.Search in Google Scholar PubMed PubMed Central

5. Shaw, JE, Sicree, RA, Zimmet, PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14. https://doi.org/10.1016/j.diabres.2009.10.007.Search in Google Scholar PubMed

6. Zimmet, P, Alberti, KG, Magliano, DJ, Bennett, PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 2016;12:616–22. https://doi.org/10.1038/nrendo.2016.105.Search in Google Scholar PubMed

7. Kharroubi, AT, Darwish, HM. Diabetes mellitus: the epidemic of the century. World J Diabetes 2015;6:850–67. https://doi.org/10.4239/wjd.v6.i6.850.Search in Google Scholar PubMed PubMed Central

8. Naghavi, M, Shahraz, A, Sepanlou, S, Dicker, D, Naghavi, P, Pourmalek, F, et al. Health transition in Iran toward chronic diseases based on results of global burden of disease 2010. Arch Iran Med 2013;36:120–6. 0141705/AIM.005.Search in Google Scholar

9. Esteghamati, A, Larijani, B, Aghajani, MH, Ghaemi, F, Kermanchi, J, Shahrami, A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of national program for prevention and control of diabetes (NPPCD-2016). Sci Rep 2017;7:13461. https://doi.org/10.1038/s41598-017-13379-z.Search in Google Scholar PubMed PubMed Central

10. Bakay, M, Pandey, R, Hakonarson, H. Genes involved in type 1 diabetes: an update. Genes 2013;4:499–521. https://doi.org/10.3390/genes4030499.Search in Google Scholar PubMed PubMed Central

11. Wong, S, Karttunen, J, Dumont, C, Wen, L, Visintin, I, Pilip, I, et al. Identification of an MHC class I-restricted autoantigen in type1 diabetes by screening an organ-specific cDNA library. Nat Med 1999;5:1026–31. https://doi.org/10.1038/12465.Search in Google Scholar PubMed

12. Janghorbani, M, Van Dam, RM, Willett, WC, Hu, FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495–505. https://doi.org/10.1093/aje/kwm106.Search in Google Scholar

13. Horikawa, Y, Enya, M. Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Curr Diabetes Rep 2019;19:12. https://doi.org/10.1007/s11892-019-1130-9.Search in Google Scholar

14. Sharma, A, Moore, M, Marcora, E, Lee, J, Oiu, Y, Samaras, S, et al. The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol 1999;19:704–13. https://doi.org/10.1128/mcb.19.1.704.Search in Google Scholar

15. Itkin-Ansari, P, Marcora, E, Geron, I, Tyrberg, B, Demeterco, C, Hao, E, et al. NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor. Dev Dynam 2005;233:946–53. https://doi.org/10.1002/dvdy.20443.Search in Google Scholar

16. Li, H, Wang, Z, Li, Y, Fang, R, Wang, H, Shi, H, et al. Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic beta-cells. J Biol Chem 2018;293:2053–65. https://doi.org/10.1074/jbc.m117.809582.Search in Google Scholar

17. Liu, M, Pereira, FA, Price, SD, Chu, MJ, Shope, C, Himes, D, et al. Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes Dev 2000;14:2839–54. https://doi.org/10.1101/gad.840500.Search in Google Scholar

18. Rubio-Cabezas, O, Minton, JA, Kantor, I, Williams, D, Ellard, S, Hattersley, AT. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes 2010;59:2326–31. PMid:16909454 PMCid:PMC2080453. https://doi.org/10.2337/db10-0011.Search in Google Scholar

19. Boraska, V, Terzić, J, Škrabić, V, Čaćev, T, Bučević-Popović, V, Peruzović, M, et al. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in dalmatian population of southern Croatia. Croat Med J 2006;47:571–8.Search in Google Scholar

20. Yamada, S, Motohashi, Y, Yanagawa, T, Maruyama, T, Kasuga, A, Hirose, H, et al. NeuroD/BETA2 gene G3A polymorphism may affect onset pattern of type 1 diabetes in Japanese. Diabetes Care 2001;24:4. https://doi.org/10.2337/diacare.24.8.1438.Search in Google Scholar

21. Oliverira, C, Hauache, O, Vieira, J, Maciel, R, Sjoroos, M, Canani, L, et al. The Ala45Thr polymorphism of NEUROD1 is associated with type 1 diabetes in Brazilian women. Diabetes Metab 2005;31:599–602. https://doi.org/10.1016/s1262-3636(07)70237-9.Search in Google Scholar

22. Vella, A, Howson, J, Barratt, B, Twells, R, Rance, H, Nutland, S, et al. Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes. Diabetes 2004;53:1158–61. https://doi.org/10.2337/diabetes.53.4.1158.Search in Google Scholar PubMed

23. Dupont, S, Dina, C, Hani, E, Froguel, P. Absence of replication in the French population of the association between beta 2/NEUROD-A45T polymorphism and type 1 diabetes. Diabetes Metab 1999;25:516–17. DM-11-1999-25-6-1262-3636-101019-EVT52.Search in Google Scholar

24. Cinek, O, Dřevínek, P, Šumník, Z, Bendlová, B, Sedláková Pn, KS, et al. NEUROD polymorphism Ala45Thr is associated with type 1 diabetes mellitus in Czech children. Diabetes Res Clin Pract 2003;60:49–56. https://doi.org/10.1016/s0168-8227(02)00251-6.Search in Google Scholar

25. Owerbach, D, Naya, FJ., Tsai, M-J, Allander, SV, Powell, DR, Gabbay, KH. Analysis of candidate genes for susceptibility to type I diabetes. Diabetes 1997;46:6. https://doi.org/10.2337/diabetes.46.6.1069.Search in Google Scholar

26. Hansen, L, Jensen, JN, Urioste, S, Petersen, HV, Pociot, F, Eiberg, H, et al. NeuroD/BETA2 gene variability and diabetes no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Diabetes 2000;49:3. https://doi.org/10.2337/diabetes.49.5.876.Search in Google Scholar

27. Awata, T, Inoue, K, Inoue, I, Abe, T, Takino, H, Kanazawa, Y, et al. Lack of association of the Ala45Thr variant in the BETA2:NEUROD1 with type 1 diabetes in Japanese. Diabetes Res Clin Pract 2000;49:3. https://doi.org/10.1016/s0168-8227(00)00118-2.Search in Google Scholar

28. Iwata, I, Nagafuchi, S, Nakashima, H, Kondo, S, Koga, T, Yokogawa, Y, et al. Association of polymorphism in the NeuroD/BETA 2 gene with type 1 diabetes in the Japanese. Diabetes 1999;48:4. https://doi.org/10.2337/diabetes.48.2.416.Search in Google Scholar PubMed

29. Association, AD. Standards of medical care in diabetes. In: MatthewRiddle, CM, editor. Diabetes care; 2019:204 p.Search in Google Scholar

30. Gonsorcikova, L, Pruhova, S, Cinek, O, Ek, J, Pelikanova, T, Jorgensen, T, et al. Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1. Pediatr Diabetes 2008;9:367–72. https://doi.org/10.1111/j.1399-5448.2008.00379.x.Search in Google Scholar PubMed

31. Malecki, M, Klupa, T, Moczulski, D, Rogus, J. The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 1 diabetes mellitus in Caucasians. Exp Clin Endocrinol Diabetes 2003;111:251–4. https://doi.org/10.1055/s-2003-41282.Search in Google Scholar PubMed

32. Kavvoura, FK, Ioannidis, JP. Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis. Hum Genet 2005;116:192–9. https://doi.org/10.1007/s00439-004-1224-5.Search in Google Scholar PubMed

Received: 2019-09-22
Accepted: 2020-06-29
Published Online: 2020-08-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Research Articles
  3. Analysis of the alpha galactosidase gene: mutation profile and description of two novel mutations with extensive literature review in Turkish population
  4. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey
  5. Risk of adrenal insufficiency following intra-articular or periarticular corticosteroid injections among children with chronic arthritis
  6. Vitamin D status is related to severity at onset of diabetes and worse glycemic control
  7. Reassessing vitamin D supplementation in preterm infants: a prospective study and review of the literature
  8. Mutations in PMM2 gene in four unrelated Spanish families with polycystic kidney disease and hyperinsulinemic hypoglycemia
  9. Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes
  10. Identification of nucleotide polymorphism within the NeuroD1 candidate gene and its association with type 1 diabetes susceptibility in Iranian people by polymerase chain reaction-restriction fragment length polymorphism
  11. Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran
  12. Clinical features of the diabetes eating problem survey–revised Turkish version in children and adolescent with type 1 diabetes
  13. Ambulatory blood pressure profile in office normotensive obese children: prevalence of masked hypertension and impact of parental hypertension
  14. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review
  15. Short Communication
  16. Screening for imprinting disorders in 58 patients with clinically diagnosed idiopathic short stature
  17. Case Reports
  18. ROHHAD syndrome – A still unrecognized cause of childhood obesity: report of three cases
  19. Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy
  20. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers
  21. GCK-MODY in a child with cystic fibrosis: the doubt of the treatment plan
Downloaded on 31.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0441/pdf
Scroll to top button